Psyence BiomedicalPBMWWPreferred / convertible

13F holders, Q2 2026 (June 30)
19holders
2new positions
2sold out
1famous investor
$0.02avg. 13F price*

At the end of Q2 2026, 19 institutions reported holding Psyence Biomedical Ltd. (PBMWW) in their 13F filings, unchanged from Q1 2026. 2 opened new positions and 2 sold out. The largest holders were Harraden Circle Investments, LLC ($28K), Polar Asset Management Partners Inc. ($17K) and MMCAP International Inc. SPC ($15K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).

Company
Psyence Biomedical Ltd.
CUSIP
74449F118
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q1 2024: 30Q1 2024Q2 2024: 28Q2 2024Q3 2024: 23Q3 2024Q4 2024: 22Q4 2024Q1 2025: 23Q1 2025Q2 2025: 23Q2 2025Q3 2025: 23Q3 2025Q4 2025: 21Q4 2025Q1 2026: 19Q1 2026Q2 2026: 19Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions2$212
Exits2$1K

All 13F filers, Q1 2026 → Q2 2026: 27,619 shares bought and 129,407 shares sold, net −101,788 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 19 holders

Harraden Circle Investments, LLC — Reduce -0.1% 1,149,000 $28K
Polar Asset Management Partners Inc. — No change 733,000 $17K
MMCAP International Inc. SPC — No change 600,000 $15K
Toronto Dominion Bank — Reduce -0.1% 503,012 $12K
Calamos Advisors LLC — No change 500,000 $11K
Saba Capital Management, L.P. — No change 297,847 $7K
Clear Street Group Inc. — Reduce 0.0% 257,202 $6K
Goldman Sachs Group Inc. — No change 200,117 $5K
LMR Partners LLP — No change 200,000 $5K
D. E. Shaw & Co. — No change 175,352 $4K
TENOR CAPITAL MANAGEMENT Co., L.P. — No change 150,000 $4K
Wolverine Asset Management LLC — No change 147,101 $4K
Aristeia Capital, L.L.C. — Reduce -46.4% 115,319 $3K
LPL Financial LLC — No change 49,095 $1K
Mint Tower Capital Management B.V. — No change 50,000 $1K
Parallel Advisors, LLC — No change 27,500 $668
Susquehanna International Group, LLP — New 10,119 $212
Ancora Advisors LLC — No change 5,000 $121
SkyView Investment Advisors, LLC — New 17,500 $0

"% of holder's portfolio" is PBMWW's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.